13F

Stock

Regeneron Pharmaceuticals, Inc.

REGN · held by 5 managers

Reported value

$198.4M

Holders

5

+0 new · −0 exited

Holders’ est. mark

$1.39M

Price effect on 3 books still in the name

Largest holder

$164.6M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC228.2K$164.6MHeld
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main30.2K$21.8M$923.9KAdded$2.31M
Swiss Life Asset Management Ltd13.5K$9.71M$415KAdded$1.1M
Leonteq Securities AG2.79K$2.01M$49.6KAdded$964.5K
Marex Group plc330$238.1KHeld

Positions as of Q4 2022. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.